Effect of Early Recombinant Human Erythropoietin on Neurodevelopmental Outcomes at Age 5 Years-Reply

JAMA. 2021 Apr 13;325(14):1471-1472. doi: 10.1001/jama.2021.0836.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Child, Preschool
  • Erythropoietin*
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Recombinant Proteins

Substances

  • Recombinant Proteins
  • Erythropoietin